0000904454-05-000045.txt : 20120629
0000904454-05-000045.hdr.sgml : 20120629
20050120133407
ACCESSION NUMBER: 0000904454-05-000045
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050120
DATE AS OF CHANGE: 20050120
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: DOMAIN PUBLIC EQUITY PARTNERS LP
CENTRAL INDEX KEY: 0001219248
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: SC 13G/A
MAIL ADDRESS:
STREET 1: ONE PALMER SQUARE
CITY: PRINCETON
STATE: NJ
ZIP: 08542
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: SONUS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000949858
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 954343413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-45969
FILM NUMBER: 05538275
BUSINESS ADDRESS:
STREET 1: 22026 2OTH AVE SE
STREET 2: STE 102
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 2064879500
MAIL ADDRESS:
STREET 1: 22026 20TH AVENUE SE, SUITE 102
CITY: BOTHELL
STATE: WA
ZIP: 98021
SC 13G/A
1
s13ga_0119-2005sonus.txt
SCHEDULE 13G/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 2)(1)
Sonus Pharmaceuticals, Inc.
-------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
835692 10 4
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2004
--------------------------------------------------------------------------------
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
-----------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 835692 10 4 Page 2 of 4 Pages
--------------------------------------------------------------------------------
1) Name of Reporting Person Domain Public Equity Partners, L.P.
I.R.S. Identification
No. of Above Person
(Entities Only)
--------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Citizenship or Place Delaware of Organization
--------------------------------------------------------------------------------
Number of 5) Sole Voting 1,354,819 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon exercise
With of warrants)
6) Shared Voting
Power -0-
------------------------------------------
7) Sole Disposi- 1,354,819 shares
tive Power of Common Stock
(including shares
issuable upon exercise
of warrants)
------------------------------------------
8) Shared
Dispositive Power -0-
------------------------------------------
9) Aggregate Amount Beneficially 1,354,819 shares
Owned by Each Reporting person of Common Stock
(including shares
issuable upon exercise
of warrants)
--------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
--------------------------------------------------------------------------------
11) Percent of Class
Represented by 6.2%
Amount in Row (9)
--------------------------------------------------------------------------------
12) Type of Reporting Person PN
-2-
CUSIP No. 835692 10 4 Page 3 of 4 Pages
Amendment No. 2 to Schedule 13G
-------------------------------
Reference is hereby made to the statement on Schedule 13G filed on
August 6, 2003 and Amendment No. 1 thereto filed on January 22, 2004 (as so
amended, the "Schedule 13G"). Terms defined in the Schedule 13G are used herein
as so defined.
The following Items of the Schedule 13G are hereby amended and
restated as follows:
Item 4 - Ownership.
(a) Amount Beneficially Owned:
1,354,819 shares of Common Stock (including shares issuable upon
exercise of warrants)
(b) Percent of Class:
6.2 %
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
1,354,819 shares of Common Stock (including shares issuable upon
exercise of warrants)
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition of:
1,354,819 shares of Common Stock (including shares issuable upon
exercise of warrants)
(iv) shared power to dispose or to direct the disposition of: -0-
-3-
CUSIP No. 835692 10 4 Page 4 of 4 Pages
Signature:
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DOMAIN PUBLIC EQUITY PARTNERS, L.P.
By: Domain Public Equity Associates, L.L.C.,
General Partner
By: Domain Associates, L.L.C., Managing Member
By /s/ Kathleen K. Schoemaker
---------------------------------------------------------
Managing Member
Date: January 13, 2005
-4-